14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
The socioeconomic fallout of COVID-19 represents an enormous challenge for the construction sector, ...
Read More >
Travel and Entertainment Provider Failed to Address EEO Complaints, Federal Agency Charges - LAS V...
Read More >
According to a recent University of California Irvine study, scientists predict that with increasing...
Read More >
With the explosive growth in connected working and living, data centres are attracting an increasing...
Read More >
Your company has just made its largest acquisition ever and your CEO says that he wants you to have ...
Read More >
The State of New Jersey has passed several laws in the wage-hour area that are definitely pro-employ...
Read More >